The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
The proposed life sciences research and development centre in North of England region of UK will support acceleration of the company’s research in the areas of biotechnology, health and life sciences
The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
Subscribe To Our Newsletter & Stay Updated
